Detalhe da pesquisa
1.
A 24-Week, All-Oral Regimen for Rifampin-Resistant Tuberculosis.
N Engl J Med
; 387(25): 2331-2343, 2022 12 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-36546625
2.
The Safety and Tolerability of Linezolid in Novel Short-Course Regimens Containing Bedaquiline, Pretomanid, and Linezolid to Treat Rifampicin-Resistant Tuberculosis: An Individual Patient Data Meta-analysis.
Clin Infect Dis
; 78(3): 730-741, 2024 03 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-37874021
3.
Overcoming BCR::ABL1 dependent and independent survival mechanisms in chronic myeloid leukaemia using a multi-kinase targeting approach.
Cell Commun Signal
; 21(1): 342, 2023 11 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-38031192
4.
Recent insights into the effects of metabolism on breast cancer cell dormancy.
Br J Cancer
; 127(8): 1385-1393, 2022 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-35715635
5.
Pathogenic Mannheimia haemolytica Invades Differentiated Bovine Airway Epithelial Cells.
Infect Immun
; 87(6)2019 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-30962401
6.
Pregnancy Outcomes in Multidrug-Resistant Tuberculosis in TB-PRACTECAL.
Clin Infect Dis
; 2024 Feb 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-38419566
7.
Multidrug-resistant tuberculosis.
Lancet
; 394(10195): 298-299, 2019 07 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-31354136
8.
Cross-serotype immunity induced by immunization with a conserved rhinovirus capsid protein.
PLoS Pathog
; 9(9): e1003669, 2013.
Artigo
em Inglês
| MEDLINE | ID: mdl-24086140
9.
Short oral regimens for pulmonary rifampicin-resistant tuberculosis (TB-PRACTECAL): an open-label, randomised, controlled, phase 2B-3, multi-arm, multicentre, non-inferiority trial.
Lancet Respir Med
; 12(2): 117-128, 2024 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-37980911
10.
Beta variant COVID-19 protein booster vaccine elicits durable cross-neutralization against SARS-CoV-2 variants in non-human primates.
Nat Commun
; 14(1): 1309, 2023 03 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-36894558
11.
Beta-containing bivalent SARS-CoV-2 protein vaccine elicits durable broad neutralization in macaques and protection in hamsters.
Commun Med (Lond)
; 3(1): 75, 2023 May 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-37237062
12.
WHO recommendations for multidrug-resistant tuberculosis.
Lancet
; 388(10057): 2234, 2016 11 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-27825500
13.
Cost-effectiveness of short, oral treatment regimens for rifampicin resistant tuberculosis.
PLOS Glob Public Health
; 2(12): e0001337, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-36962909
14.
Protein-based SARS-CoV-2 spike vaccine booster increases cross-neutralization against SARS-CoV-2 variants of concern in non-human primates.
Nat Commun
; 13(1): 1699, 2022 03 31.
Artigo
em Inglês
| MEDLINE | ID: mdl-35361754
15.
TB-PRACTECAL: study protocol for a randomised, controlled, open-label, phase II-III trial to evaluate the safety and efficacy of regimens containing bedaquiline and pretomanid for the treatment of adult patients with pulmonary multidrug-resistant tuberculosis.
Trials
; 23(1): 484, 2022 Jun 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-35698158
16.
Efficacy, safety and tolerability of linezolid for the treatment of XDR-TB: a study in China.
Eur Respir J
; 47(5): 1591-2, 2016 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-27132271
17.
Population pharmacokinetics and pharmacodynamics of investigational regimens' drugs in the TB-PRACTECAL clinical trial (the PRACTECAL-PKPD study): a prospective nested study protocol in a randomised controlled trial.
BMJ Open
; 11(9): e047185, 2021 09 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-34489274
18.
Engineering cartilage graft using mesenchymal stem cell laden polyacrylamide-galactoxyloglucan hydrogel for transplantation.
J Biomater Appl
; 36(3): 541-551, 2021 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-34018854
19.
Outcomes with a shorter multidrug-resistant tuberculosis regimen from Karakalpakstan, Uzbekistan.
ERJ Open Res
; 7(1)2021 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-33585652
20.
Vaccination with SARS-CoV-2 Spike Protein and AS03 Adjuvant Induces Rapid Anamnestic Antibodies in the Lung and Protects Against Virus Challenge in Nonhuman Primates.
bioRxiv
; 2021 Mar 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-33688652